AWFIS SPACE SOLUTIONS LIMITED

Recommendation history

• Q4 2026HoldHold: Awfis delivered strong FY26 execution, with revenue up 24% to INR1,493 crore, operating EBITDA up 37% to INR550 crore at a 36.8% margin, and normalized EBITDA up 27% to INR213 crore. FY27 revenue growth guidance of 25%-27% is credible on paper, supported by enterprise/GCC demand and premiumization, but the call exposed execution uncertainty: blended occupancy remains only 76%, net seat additions were about 22,000 versus 30,000 gross, and management did not quantify the expected margin or cash-flow benefit from the premium strategy.
• Q3 2026HoldHold: Q3 was solid but not clean enough for a buy. Revenue rose 20% YoY to Rs.382 crore, operating EBITDA rose 30% to Rs.139 crore at a 36.5% margin, and occupancy improved to 75%; however, FY26 seat-addition guidance was cut from 40,000 to 32,000–33,000 and Awfis Transform remains weak. The bull case is occupancy-led margin expansion and GCC demand, while the key tension is whether delayed seat ramp-up and fit-out execution normalize as management expects.
• 2025-09-24HoldHold: Awfis delivered strong FY25 growth, with revenue up 42% to INR1,208 crore, 134,000 operational seats, 73% overall occupancy and 84% occupancy at mature centers. The asset-light managed aggregation model now covers 64% of centers and supports attractive stated ROCE of nearly 62%, but the AGM provided no FY26 revenue, margin, earnings or cash-flow guidance, leaving the investment case dependent on execution rather than a fully underwritten earnings outlook.
• Q4 2024HoldHold: Awfis delivered strong FY25 execution—revenue rose 42% to INR1,208 crore and operating EBITDA rose 64% to INR402 crore, with reported margin at 33.3%; Q4 revenue grew 46% to INR340 crore and EBITDA 73% to INR116 crore. The bull case is 30%+ FY26 growth, roughly 39,000 additional seats, and occupancy-led operating leverage, but the call does not yet justify a clean buy: FY26 guidance implies deceleration, exit occupancy was only 73%, capex exceeded plan, and IGAAP-equivalent EBITDA margin was just 13.9% versus 33.3% under Ind AS 116.
• Q3 2024HoldHold: Awfis delivered strong Q3 execution, with revenue up 44% YoY to INR318 crore, operating EBITDA up 59% to INR107 crore and reported EBITDA margin at 33.8%; occupancy was 73% across the portfolio and 84% at centers older than 12 months. However, the more economically relevant IGAAP-equivalent EBITDA margin was 14.7%, while analyst pushback highlighted weak underlying free cash flow after lease-related payments and continued capex needs, making this a strong operating quarter but not yet a clean buy.
• Q1 2024BuyBuy: Q1 showed strong operating momentum, with revenue of INR258 crore (+37% YoY), EBITDA of INR79 crore (+56%) at a 30.7% reported margin, and INR15 crore IGAAP-equivalent PAT versus a year-ago loss. The asset-light model, 67% managed-aggregation seat mix, INR185 crore liquidity and only INR30 crore gross debt support attractive scaling, but the underlying IGAAP-equivalent EBITDA margin was only 11.5% and blended occupancy remained 71%, leaving execution and ramp-up risk.
• Q2 2024BuyBuy: Awfis delivered a strong Q2/H1 with Q2 revenue up 40% to Rs.292 crore, operating EBITDA up 67% to Rs.100 crore and Ind AS 116-adjusted EBITDA margin expanding 550 bps to 34.3%; iGAAP-equivalent EBITDA also rose 160% with margin at 14.9%. Demand remains robust, with 25,000 seats sold in H1 versus 37,000 in all FY24, 73% blended occupancy and 84% occupancy at mature centers. The key tension is that reported profitability is heavily affected by lease accounting, while occupancy on the expanding base remains only 73% and management declined to quantify an upgraded full-year outlook.